Clinical Trial Update: Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/Phase 2 clinical trial evaluating the therapeutic vaccine ISA101/ISA101b for advanced or recurrent cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• ISA101
• ISA101b (ISA101b)

Snippet

Sponsor: ISA Pharmaceuticals | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: COMPLETED